The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 11 , ISSUE 2 ( March, 2010 ) > List of Articles

RESEARCH ARTICLE

Comparative Evaluation of Ketoconazole Tablet and Topical Ketoconazole 2% in Orabase in Treatment of Candida-Infected Denture Stomatitis

Faezeh Khozeimeh, Omid Savabi, Mohammad Ali Shahtalebi, Mojtaba Noori

Citation Information : Khozeimeh F, Savabi O, Shahtalebi MA, Noori M. Comparative Evaluation of Ketoconazole Tablet and Topical Ketoconazole 2% in Orabase in Treatment of Candida-Infected Denture Stomatitis. J Contemp Dent Pract 2010; 11 (2):17-24.

DOI: 10.5005/jcdp-11-2-17

License: CC BY-NC 3.0

Published Online: 01-03-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

Denture stomatitis is a common and recurring problem of denture wearers. Ketoconazole tablet is one of the antimycotic drugs that often has been used to treat this condition, but systemic use of this drug has some adverse effects that frequently lead to unfavorable compliance and treatment failure. This study was designed to compare the efficacy of topical ketoconazole 2% in orabase and ketoconazole tablet.

Methods and Materials

Thirty patients with denture stomatitis (positive culture) were divided into two groups. The first group received ketoconazole tablet (orally used 200 mg per day) for 14 days and the second group received 2% topical ketoconazole in orabase applied twice daily on the mucosal denture surface. Candida cultures were taken from the palatal mucosa before and on days 7 and 14 after commencement of the therapy. The mean of colonies before and 7 and 14 days after medication were calculated. Oneway ANOVA and paired t-test were used for data analysis (α=0.05).

Results

The mean of colonies number before receiving medication in the tablet and topical application groups were 454 and 441 respectively. The mean of colonies number after receiving medication in tablet and topical application group were 137 and 176 (on the seventh day) and 122 and 96 (on the 14th day), respectively; there was no significant difference between the two groups after medication (p=0.18).

Conclusion

Topical ketoconazole 2% in orabase can be useful in managing denture stomatitis. This topical medication has fewer side effects, whereas systemic administration of ketoconazole tablet is associated with some complications.

Clinical Significance

The application of topical ketoconazole 2% in orabase ointment can be considered in the treatment of denture stomatitis and has comparable efficacy with the ketoconazole tablet.

Citation

Khozeimeh F, Shahtalebi MA, Noori M, Savabi O. Comparative Evaluation of Ketoconazole Tablet and Topical Ketoconazole 2% in Orabase in Treatment of Candida-infected Denture Stomatitis. J Contemp Dent Pract [Internet]. 2010 March; 11(2):017-024. Available from: http://www.thejcdp.com/journal/view/volume11-issue2-khozeimeh.


PDF Share
  1. Burket's oral medicine. 11th ed. Hamilton, Ontario: BC Deeker; 2008. p. 81-4.
  2. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy Suppl. 1976; 36:1-103.
  3. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol. 1981; 10(2):65-80.
  4. [Oral mucosa conditions and denture status in 127 nursing home residents]. Tandlaegebladet. 1983; 87(9):307-11.
  5. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990; 19(4):170-6.
  6. Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis. Oral Microbiol Immunol. 1999; 14(3):183-9.
  7. The significance of Candida albicans in denture stomatitis. Scand J Dent Res. 1974; 82(2):151-90.
  8. Denture stomatitis— a review of the aetiology, diagnosis and management. Aust Dent J. 1992; 37(2):107-14.
  9. Treatment of Candidainfected denture stomatitis with a miconazole lacquer. Oral Surg Oral Med Oral Pathol. 1994; 78(3):306-11.
  10. Denture sore mouth and angular cheilitis: a preliminary investigation into their possible association with Candida infection. Dent Pract 1957; 7:212-7.
  11. Denture stomatitis I. The etiology in relation to trauma and infection. Acta Odontol Scand. 1970; 28(1):71-92.
  12. The rational management of oral candidosis associated with dentures. N Z Dent J. 1986; 82(369):81-4.
  13. Miconazole lacquer compared with gel in treatment of denture stomatitis. Scand J Dent Res. 1994; 102(6):361-6.
  14. Miconazole gel compared with Zataria multiflora Boiss. gel in the treatment of denture stomatitis. Phytother Res. 2006; 20(11):966-9.
  15. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. Oral Dis. 2005; 11(5):309-13.
  16. Antifungal topical therapy in oral chronic candidosis. A comparative study. Med Oral. 2002; 7(4):260-70.
  17. Ketoconazole resistant oral candidiasis in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84(1):3-4.
  18. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004; 38(2):161-89.
  19. S. Food and Drug Administration, Center for Drug Evaluation and Research. Drugs @ FDA. Drug detail: Nizoral [Internet]. Washington (DC): U.S. Department of Health and Human Services [cited 2007 Feb 15]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
  20. Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. J Acquir Immune Defic Syndr. 2004; 35(2):144-50.
  21. Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer. 2008; 112(1):204-11.
  22. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82(4):402-7.
  23. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients. Am J Med. 1998; 104(1):33-9.
  24. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers. Oral surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(5):632-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.